261 related articles for article (PubMed ID: 27141425)
1. Quantitative analysis of nanoparticle transport through in vitro blood-brain barrier models.
Berg C
Tissue Barriers; 2016; 4(1):e1143545. PubMed ID: 27141425
[TBL] [Abstract][Full Text] [Related]
2. Evolution of Nanoparticle Protein Corona across the Blood-Brain Barrier.
Cox A; Andreozzi P; Dal Magro R; Fiordaliso F; Corbelli A; Talamini L; Chinello C; Raimondo F; Magni F; Tringali M; Krol S; Jacob Silva P; Stellacci F; Masserini M; Re F
ACS Nano; 2018 Jul; 12(7):7292-7300. PubMed ID: 29953205
[TBL] [Abstract][Full Text] [Related]
3. Optimal nanoparticle design for effective transport through the blood-brain barrier.
Park K
J Control Release; 2019 Feb; 295():290. PubMed ID: 30704674
[No Abstract] [Full Text] [Related]
4. The role of non-endothelial cells on the penetration of nanoparticles through the blood brain barrier.
Moura RP; Almeida A; Sarmento B
Prog Neurobiol; 2017 Dec; 159():39-49. PubMed ID: 28899762
[TBL] [Abstract][Full Text] [Related]
5. Nanoparticle transport across the blood brain barrier.
Grabrucker AM; Ruozi B; Belletti D; Pederzoli F; Forni F; Vandelli MA; Tosi G
Tissue Barriers; 2016; 4(1):e1153568. PubMed ID: 27141426
[TBL] [Abstract][Full Text] [Related]
6. A method for evaluating nanoparticle transport through the blood-brain barrier in vitro.
Guarnieri D; Muscetti O; Netti PA
Methods Mol Biol; 2014; 1141():185-99. PubMed ID: 24567140
[TBL] [Abstract][Full Text] [Related]
7. PLGA nanoparticles prepared by nano-emulsion templating using low-energy methods as efficient nanocarriers for drug delivery across the blood-brain barrier.
Fornaguera C; Dols-Perez A; Calderó G; García-Celma MJ; Camarasa J; Solans C
J Control Release; 2015 Aug; 211():134-43. PubMed ID: 26057857
[TBL] [Abstract][Full Text] [Related]
8. Nano-enabled delivery systems across the blood-brain barrier.
Hwang SR; Kim K
Arch Pharm Res; 2014 Jan; 37(1):24-30. PubMed ID: 24170511
[TBL] [Abstract][Full Text] [Related]
9. A TEM protocol for quality assurance of in vitro cellular barrier models and its application to the assessment of nanoparticle transport mechanisms across barriers.
Ye D; Dawson KA; Lynch I
Analyst; 2015 Jan; 140(1):83-97. PubMed ID: 25303735
[TBL] [Abstract][Full Text] [Related]
10. Internal benchmarking of a human blood-brain barrier cell model for screening of nanoparticle uptake and transcytosis.
Ragnaill MN; Brown M; Ye D; Bramini M; Callanan S; Lynch I; Dawson KA
Eur J Pharm Biopharm; 2011 Apr; 77(3):360-7. PubMed ID: 21236340
[TBL] [Abstract][Full Text] [Related]
11. ApoE-modified solid lipid nanoparticles: A feasible strategy to cross the blood-brain barrier.
Dal Magro R; Ornaghi F; Cambianica I; Beretta S; Re F; Musicanti C; Rigolio R; Donzelli E; Canta A; Ballarini E; Cavaletti G; Gasco P; Sancini G
J Control Release; 2017 Mar; 249():103-110. PubMed ID: 28153761
[TBL] [Abstract][Full Text] [Related]
12. Shuttle-mediated nanoparticle transport across an in vitro brain endothelium under flow conditions.
Falanga AP; Pitingolo G; Celentano M; Cosentino A; Melone P; Vecchione R; Guarnieri D; Netti PA
Biotechnol Bioeng; 2017 May; 114(5):1087-1095. PubMed ID: 27861732
[TBL] [Abstract][Full Text] [Related]
13. Nano-interventions for neurodegenerative disorders.
Fernandes C; Soni U; Patravale V
Pharmacol Res; 2010 Aug; 62(2):166-78. PubMed ID: 20153429
[TBL] [Abstract][Full Text] [Related]
14. A relevant in vitro rat model for the evaluation of blood-brain barrier translocation of nanoparticles.
Garcia-Garcia E; Gil S; Andrieux K; Desmaële D; Nicolas V; Taran F; Georgin D; Andreux JP; Roux F; Couvreur P
Cell Mol Life Sci; 2005 Jun; 62(12):1400-8. PubMed ID: 15905957
[TBL] [Abstract][Full Text] [Related]
15. In vitro assessment of alkylglyceryl-functionalized chitosan nanoparticles as permeating vectors for the blood-brain barrier.
Lien CF; Molnár E; Toman P; Tsibouklis J; Pilkington GJ; Górecki DC; Barbu E
Biomacromolecules; 2012 Apr; 13(4):1067-73. PubMed ID: 22409486
[TBL] [Abstract][Full Text] [Related]
16. Nanomedicine as a non-invasive strategy for drug delivery across the blood brain barrier.
Tam VH; Sosa C; Liu R; Yao N; Priestley RD
Int J Pharm; 2016 Dec; 515(1-2):331-342. PubMed ID: 27769885
[TBL] [Abstract][Full Text] [Related]
17. Nose-to-Brain Delivery: Investigation of the Transport of Nanoparticles with Different Surface Characteristics and Sizes in Excised Porcine Olfactory Epithelium.
Mistry A; Stolnik S; Illum L
Mol Pharm; 2015 Aug; 12(8):2755-66. PubMed ID: 25997083
[TBL] [Abstract][Full Text] [Related]
18. Strategies to overcome the barrier: use of nanoparticles as carriers and modulators of barrier properties.
Rempe R; Cramer S; Qiao R; Galla HJ
Cell Tissue Res; 2014 Mar; 355(3):717-26. PubMed ID: 24585360
[TBL] [Abstract][Full Text] [Related]
19. Nanoparticle delivery to the brain--By focused ultrasound and self-assembled nanoparticle-stabilized microbubbles.
Åslund AKO; Berg S; Hak S; Mørch Ý; Torp SH; Sandvig A; Widerøe M; Hansen R; de Lange Davies C
J Control Release; 2015 Dec; 220(Pt A):287-294. PubMed ID: 26518721
[TBL] [Abstract][Full Text] [Related]
20. Nanoparticles and the blood-brain barrier: advancing from in-vitro models towards therapeutic significance.
Mc Carthy DJ; Malhotra M; O'Mahony AM; Cryan JF; O'Driscoll CM
Pharm Res; 2015 Apr; 32(4):1161-85. PubMed ID: 25446769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
